Abstract:The protein transient receptor potential melastatin type 8 (TRPM8), a non-selective, calcium (Ca2+)-permeable ion channel is implicated in several pathological conditions, including neuropathic pain states. In our previous research endeavors, we have identified β-lactam derivatives with high hydrophobic character that exhibit potent and selective TRPM8 antagonist activity. This work describes the synthesis of novel derivatives featuring C-terminal amides and diversely substituted N'-terminal monobenzyl groups in an attempt to increase the total polar surface area (TPSA) in this family of compounds. The primary goal was to assess the influence of these substituents on the inhibition of menthol-induced cellular Ca2+ entry, thereby establishing critical structure-activity relationships. While the substitution of the tert-butyl ester by isobutyl amide moieties improved the antagonist activity, none of the N'-monobencyl derivatives, regardless of the substituent on the phenyl ring, achieved the activity of the model dibenzyl compound. The antagonist potency of the most effective compounds was subsequently verified using Patch-Clamp electrophysiology experiments. Furthermore, we evaluated the selectivity of one of these compounds against other members of the transient receptor potential (TRP) ion channel family and some receptors connected to peripheral pain pathways. This compound demonstrated specificity for TRPM8 channels. To better comprehend the potential mode of interaction, we conducted docking experiments to uncover plausible binding sites on the functionally active tetrameric protein. While the four main populated poses are located by the pore zone, a similar location to that described for the N-(3-aminopropyl)-2-[(3-methylphenyl)methoxy]-N-(2-thienylmethyl)-benzamide (AMTB) antagonist cannot be discarded. Finally, in vivo experiments, involving a couple of selected compounds, revealed significant antinociceptive activity within a mice model of cold allodynia induced by oxaliplatin (OXA).

Transient Receptor Potential Melastatin 8 Channel (TRPM8) Modulation: Cool Entryway for Treating Pain and Cancer

Molecular determinants of TRPM8 function: key clues for a cool modulation

TRPM8 Channels: A Review of Distribution and Clinical Role

Selective Inhibition of TRPM2 Channel by Two Novel Synthesized ADPR Analogues

A Structural Framework for the Polymodal Pain Sensor TRPV1

A journey from molecule to physiology and in silico tools for drug discovery targeting the transient receptor potential vanilloid type 1 (TRPV1) channel

Evidence that the cold- and menthol-sensing functions of the human TRPM8 channel evolved separately

Therapeutic potential of TRPM8 channels in cancer treatment

Cold sensor, hot topic: TRPM8 plays a role in monocyte function and differentiation

Synthesis, high-throughput screening and pharmacological characterization of β–lactam derivatives as TRPM8 antagonists

Medicinal Chemistry Perspective Of Trpm2 Channel Inhibitors: Where We Are And Where We Might Be Heading?

Characterization of New TRPM8 Modulators in Pain Perception

On the modulation of TRPM channels: Current perspectives and anticancer therapeutic implications

Mechanisms of sensory adaptation and inhibition of the cold and menthol receptor TRPM8

Thermally activated TRP channels: molecular sensors for temperature detection

Targeting nociceptive transient receptor potential channels to treat chronic pain: current state of the field

Conservation of the cooling agent binding pocket within the TRPM subfamily

TRPV1: Structure, Endogenous Agonists, and Mechanisms

β-Lactam TRPM8 Antagonists Derived from Phe-Phenylalaninol Conjugates: Structure-Activity Relationships and Antiallodynic Activity

The Role and Function of TRPM8 in the Digestive System